Showing results (141-150 of 3,225) with videos related to
Sort By:
Pageof 323
British Journal of Pharmacology|November 1, 1986
On the mechanisms of kappa-opioid-induced diuresisT P Blackburn, K R Borkowski, J Friend, et al.Journal of Internal Medicine|July 30, 2023
The GABA system, a new target for medications against cognitive impairment-Associated with neuroactive steroidsTorbjörn Bäckström, Sahruh Turkmen, Roshni Das, et al.Pharmacology, Biochemistry, and Behavior|January 1, 1982
Possible mechanism of 5-methoxy-N,N-dimethyltryptamine-induced turning behaviour in DRN lesioned ratsT P Blackburn, B Cox, C G Heapy, et al.Psychopharmacology|March 1, 1995
Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxietyG A Kennett, F Bailey, D C Piper, et al.The Journal of Biological Chemistry|November 4, 1994
Mutagenesis identifies amino-terminal residues of nerve growth factor necessary for Trk receptor binding and biological activityA Shih, G R Laramee, C H Schmelzer, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 1, 1993
Neurotrophin-4/5 is a mammalian-specific survival factor for distinct populations of sensory neuronsA M Davies, A Horton, L E Burton, et al.British Journal of Pharmacology|April 3, 1999
Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonistC Reavill, A Kettle, V Holland, et al.European Journal of Pharmacology|June 10, 1988
In vitro studies with ICI 169,369, a chemically novel 5-HT antagonistT P Blackburn, C W Thornber, R J Pearce, et al.Postgraduate Medical Journal|January 1, 1985
Interaction studies and other investigations of the pharmacology of propofol ('Diprivan')J B Glen, S C Hunter, T P Blackburn, et al.The Biochemical Journal|June 15, 1987
The identification of specific Rhesus-polypeptide-blood-group-ABH-active-glycoprotein complexes in the human red-cell membraneS Moore, C GreenPageof 323